News

Amneal targets $3B-$3.1B in 2025 revenue with strong growth drivers
Discover Amneal Pharmaceuticals' Q1 2025 insights, featuring revenue growth, CREXONT’s expansion, biosimilar contributions, and innovative drug ...
Structure draws new Buy at Citi on oral obesity drug pipeline
Citi launched its coverage of Structure Therapeutics with a Buy recommendation and a $60 per share target on Friday, citing ...
Viking among notable gainers as Pfizer raises deal prospects
Viking Therapeutics (VKTX) stock rises as Pfizer (PFE) plans to bolster its pipeline with cardiometabolic and other obesity drugs, through acquisitions. Read more here.
My Investing News3d
Market Update: Amazon Under Fire From Trump Admin, Chip Stocks Sink
FacebookTweetPin The stock market has been mostly flat this morning, but things have gotten slightly more positive as Amazon (NASDAQ: AMZN) stopped declining. The company caught fire from the Trump ...
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday
Hims & Hers Health, Inc. HIMS shares jumped 23% to $34.99 after the company announced a collaboration with Novo Nordisk to ...